ChREBP was downregulated in patients with NAFLD compared to healthy controls, and instead, SREBP1c was shown to be one of the predominant regulators of DNL in NAFLD [97]. The gene discussed is MLXIPL; the disease is metabolic dysfunction-associated steatotic liver disease.